Assessment of national cancer care network guideline-adherent treatment differences as a contributor to racial disparities in epithelial and non-epithelial ovarian cancer survival
Cancer Treatment and Research Communications · 2026
DOI: 10.1016/j.ctarc.2026.101307 ↗Kurz gefasst
Leitlinie in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Marilyn Barragan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, IL, 60612, USA. Electronic address: …. Hauptthemen laut MEDLINE: Carcinoma, Ovarian Epithelial, Guideline Adherence, Healthcare Disparities, Ovarian Neoplasms. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, University of Illinois at Chicago.
Themen: Onkologische Pflege
Abstract (Originalsprache)
OBJECTIVE: To assess National Comprehensive Cancer Network (NCCN) guideline concordance and survival for epithelial and nonepithelial ovarian cancer in Black and White patients. Guideline-concordant care is defined as treatment consistent with NCCN recommendations based on tumor subtype and stage at diagnosis. METHODS: This retrospective study included epithelial and nonepithelial ovarian cancer cases from the National Cancer Database from 2005 to 2015 for patients of White or Black race. Outcomes were NCCN guideline concordance and five-year survival following diagnosis. Factors significantly associated with guideline concordance and five-year survival in bivariate analyses were included in multivariable survival models. Survival was assessed using Kaplan-Meier estimates with log-rank tests, and adjusted hazard ratios (HRs) with 95% confidence intervals (CIs) were estimated using Cox proportional hazards models. RESULTS: Concordance with evidence-based treatment guidelines was lower among Black patients with epithelial histotypes, with no racial difference for nonepithelial types. Black patients also had a higher burden of nonepithelial histotypes relative to White patients. After adjustment for clinical and sociodemographic factors, Black patients had a higher risk of death than White patients (HR = 1.15, 95% CI 1.11-1.18), which was attenuated slightly after inclusion of guideline-concordant treatment in the model (HR = 1.13, 95% CI 1.09-1.17). CONCLUSIONS: Guideline-concordant care was associated with racial differences in survival, but the modest association suggests that additional unmeasured factors likely influence outcomes. Limitations include exclusion of cases missing stage, inability to evaluate factors occurring earlier in the treatment trajectory, and absent data regarding the extent of surgical cytoreduction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, IL, 60612, USA. Electronic address: mbarra37@uic.edu.
- Gynecologic Oncology, Translational Oncology Program, University of Illinois Cancer Center, Chicago, IL, 60612, USA.
- Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, IL, 60612, USA; Biostatistics Shared Resource, University of Illinois Cancer Center, Chicago, IL, 60612, U…
- Black Cancer Collaborative, Chicago, IL, 606012, USA.
- Division of Reproductive Science in Medicine, Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA; The Chemistry of Life Processes Institute, Developmen…
- Chemistry Department, Northeastern Illinois University, Chicago, IL, 60625, USA.
Förderung
- NCI NIH HHS
- University of Illinois at Chicago
Zitieren
APA
Barragan, M., David, S. M., Chen, Z., Richardson, K., Qiang, W., Miodragovic, D., & Peterson, C. E. (2026). Assessment of national cancer care network guideline-adherent treatment differences as a contributor to racial disparities in epithelial and non-epithelial ovarian cancer survival. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2026.101307
Vancouver
Barragan M, David SM, Chen Z, Richardson K, Qiang W, Miodragovic D, et al. Assessment of national cancer care network guideline-adherent treatment differences as a contributor to racial disparities in epithelial and non-epithelial ovarian cancer survival. Cancer Treatment and Research Communications. 2026. doi:10.1016/j.ctarc.2026.101307
BibTeX
@article{Barragan2026,
author = {Barragan, Marilyn and David, Shannon MacLaughlan and Chen, Zhengia and Richardson, Kimberly and Qiang, Wenan and Miodragovic, Denana and Peterson, Caryn E},
title = {Assessment of national cancer care network guideline-adherent treatment differences as a contributor to racial disparities in epithelial and non-epithelial ovarian cancer survival},
journal = {Cancer Treatment and Research Communications},
year = {2026},
doi = {10.1016/j.ctarc.2026.101307}
}
EUVIMED